Search bioRxiv⌕ Search

Biology subjects

Saber, J.

Publications and source records attributed to Saber, J..

2 recordsLinked to original sources

Phosphorylation of CARM1 at Ser572 preserves muscle stem cell self-renewal by restricting premature myogenic commitment

Skeletal muscle regeneration depends on satellite cells, which must balance myogenic commitment with self-renewal to maintain regenerative capacity throughout life. The methyltransferase CARM1 is a key regulator of satellite cell fate, acting through methylation of PAX7 to promote Myf5 expression and myogenic commitment. The dystrophin glycoprotein complex regulates this pathway through p38{gamma}-mediated phosphorylation of CARM1 at Ser572, however the physiological role of this phosphorylation event in vivo remains unknown. Here, we generated a phosphorylation-deficient CARM1 knock-in mouse (CARM1 SA) to determine how CARM1 Ser572 phosphorylation regulates satellite cell fate during regenerative myogenesis. Satellite cell-derived myoblasts from CARM1 SA mice exhibited reduced PAX7 expression, impaired fusion, and abnormal myotube formation despite transcriptional signatures consistent with accelerated myogenic progression. Ex vivo single-myofiber assays revealed precocious acquisition of a committed progenitor identity accompanied by a reduction in the self-renewing satellite cell population. While muscle development and regeneration following a single injury were largely preserved, repeated regenerative challenge resulted in progressive depletion of the satellite cell pool in CARM1 SA mice. Transcriptomic analysis demonstrated minimal effects under homeostatic conditions but identified substantial alterations during regeneration, including reduced expression of extracellular matrix-associated genes, impaired TGF{beta}-SMAD signaling, decreased Tgfbr3 expression, and increased MYC activity, consistent with a loss of self-renewal programs and enhanced activation. Collectively, these findings demonstrate that phosphorylation of CARM1 at Ser572 is a critical mechanism to delay satellite cell commitment, thereby maintaining a balance between self-renewal and commitment to ensure long-term maintenance of the muscle stem cell compartment.

cell biology↗

Fucoidan-Coated Layer-by-layer Lipid Nanoparticles for the Generation of CAR-Macrophages

Modulation of immune cells as therapeutic tools has gained significant clinical relevance in the treatment of cancer. Among them, macrophages represent a promising immunotherapeutic platform not only because they can internalize tumor material, but also because they profoundly shape the tumor microenvironment through cytokine production, antigen presentation, metabolic regulation, and modulation of other immune and stromal populations. Lipid Nanoparticles (LNPs) have enabled RNA therapies to the bedside and are thus considered the gold standard for gene delivery. However, optimizing LNPs for RNA delivery to macrophages remains an active area of investigation. Here, we propose the surface modification of unPEGylated LNPs using the Layer-by-Layer (LbL) approach for enhanced RNA delivery to macrophages. Specifically, we show that fucoidan, a sulfated polysaccharide, when at the outermost layer in the LbL process provides two physicochemical advantages to unPEGylated LNPs: (1) stability in PBS and (2) resistance to lyophilization in the presence of cryoprotectant. Additionally, fucoidan improves macrophage targeting and RNA transfection efficiency compared to previously synthesized hyaluronan-decorated LbL LNPs. Fucoidan LbL LNPs (Fuc-LNPs) preferentially accumulated in CD11b+ macrophages when co-cultured with U87 glioblastoma cells, which was not observed for control PEGylated LNPs. Furthermore, Fuc-LNPs induced a higher transfection of mRNA in primary human macrophages when compared to PEGylated control LNPs. Using the model mRNA encoding CAR@CD19, Fuc-LNPs generated CAR macrophages which mediated CD19 cell ablation in vitro. Altogether, these findings highlight the potential of the LbL strategy to modulate the targeting properties of LNPs, improving RNA delivery to human macrophages and encouraging further studies using LbL LNPs for the generation of CAR-Macrophages in the context of solid tumors.

bioengineering↗